Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Shogaol
Cat. No.:
OB0225LY-0386
Appearance:
Liquid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Shogaol is an active ingredient with antioxidant, anti-inflammatory and anti-tumor activity.
Synonym:
[6]-Shogaol; 6-Shogaol; 555-66-8; (E)-1-(4-Hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-shogaol; 1-(4-Hydroxy-3-methoxyphenyl)dec-4-en-3-one; 4-Decen-3-one, 1-(4-hydroxy-3-methoxyphenyl); (E)-1-(4-Hydroxy-3-methoxy-phenyl)-dec-4-en-3-one; [(E)-1-(4-Hydroxy-3-methoxyphenyl)-dec-4-en-3-one]; 1-(4-Hydroxy-3-methoxyphenyl)-4-dodecen-3-one, 9CI
CAS No.:
555-66-8
Compound CID:
5281794
Formula:
C17H24O3
Formula Weight:
276.37
Specification
Relative Density:
1.033 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Shogaol can be used in food science research or play an important role in drug development and cancer research.
Library Information
Targets:
Lipoxygenase
Pathways:
Metabolism; Autophagy
Plate Number:
AOCL-5
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 199.01 mM
